ArticleBlood advances2021

Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti-PD-1-based therapy.

Hussein A Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.